BSE filing, NSE: SHIVMED. Summary written from the filing by ALFA Finder's alert engine.
Bandaram Pharma Packtech Ltd: key numbers
- Share price
- ₹19.35
- Market cap
- ₹34.78 Cr
- Revenue (annual)
- ₹62.92 Cr
- Net profit (annual)
- ₹1.01 Cr
- P/E (TTM)
- 34.2×Sector 52.0×
- Promoter holding
- 62.66%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bandaram Pharma Packtech Ltd
All →Bandaram Pharma Packtech Board Meeting Date
Bandaram Pharma Packtech will hold a board meeting on 29 October 2026 to consider September 2026 quarter results. The trading window stays closed until 16 November 2026.
Bandaram Pharma Packtech Board Meeting Date
Bandaram Pharma Packtech has scheduled a board meeting on 30.09.2026 to consider a proposal for a scheme of arrangement or amalgamation.
Bandaram Pharma Packtech Annual General Meeting
Bandaram Pharma Packtech Limited held its Annual General Meeting on September 24, 2026, approving financial statements and re-appointing auditors and directors.
Bandaram Pharma Packtech Annual General Meeting
Bandaram Pharma Packtech submitted its Annual Report and notice for the AGM, which is now rescheduled for September 24, 2026.
Bandaram Pharma Packtech Management Change
Bandaram Pharma Packtech re-appointed its statutory auditor for 36 months and an independent director for a 60-month term, both approved in the board meeting.
Bandaram Pharma Packtech Q1 FY27 Results: Net Profit ₹0.7 Cr, Up 600.0% QoQ
Bandaram Pharma Packtech Ltd reported revenue from operations of ₹24 Cr (+196.3% YoY) and net profit of ₹0.7 Cr for Q1 FY27.
- Key figure
- Net profit ₹0.7 Cr
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.